Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/23331 |
Resumo: | Copyright © 2009 The Journal of Rheumatology. All rights reserved. |
id |
RCAP_9d04d58f1462bf013c6e5c6f2bea5556 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/23331 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortalityRheumatoid arthritisSystemic lupus erythematosusMortalityCopyright © 2009 The Journal of Rheumatology. All rights reserved.Objective. Features of systemic lupus erythematosus (SLE) are commonly observed in patients with rheumatoid arthritis (RA). However, their frequency and clinical significance are uncertain. We examined the frequency of SLE features in RA and their effect on overall mortality. Methods. We assembled a population-based incidence cohort of subjects aged ≥ 18 years first diagnosed with RA [1987 American College of Rheumatology (ACR) criteria] between 1955 and 1995. Information regarding disease characteristics, therapy, comorbidities, and SLE features (1982 ACR criteria) were collected from the complete inpatient and outpatient medical records. Cox regression models were used to estimate the mortality risk associated with lupus features. Results. The study population comprised 603 subjects with incident RA (mean age 58 yrs, 73% women) with a mean followup time of 15 years. By 25 years after RA incidence, ≥ 4 SLE features were observed in 15.5% of the subjects with RA. After adjustment for age and sex, occurrence of ≥ 4 SLE features was associated with increased overall mortality [hazard ratio (HR) 5.54, 95% confidence interval (CI) 3.59–8.53].With further adjustment for RA characteristics, therapy, and comorbidities, the association weakened but remained statistically significant (HR 2.56, 95% CI 1.60–4.08). After adjustment for age, sex, RA characteristics, therapy, and comorbidities, thrombocytopenia (2.0, 95% CI 1.2, 3.1) and proteinuria (1.8, 95% CI 1.3, 2.6) were significantly associated with mortality. Conclusion. SLE features were common in RA, given sufficient observation time. Subjects with RA who developed ≥ 4 SLE features had an increased risk of death. Proteinuria and thrombocytopenia were individually associated with an increased mortality risk.Supported in part by a grant from the National Institutes of Health, NIAMS (R01 AR46849), and the National Institutes of Health (AR-30582) US Public Health Service. Dr. Nicola was funded by a fellowship from the Fundação para a Ciência e Tecnologia, Portugal (SFRH/BD/17282/2004)Earl D. SilvermanRepositório da Universidade de LisboaIcen, MuratNicola, Paulo J.Maradit-Kremers, HilalCrowson, Cynthia S.Therneau, Terry M.Matteson, Eric L.Gabriel, Sherine E.2016-04-07T15:45:30Z20082008-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/23331engJ Rheumatol 2009;36:50–570315-162X10.3899/jrheum.080091metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:11:15Zoai:repositorio.ul.pt:10451/23331Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:40:42.650037Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality |
title |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality |
spellingShingle |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality Icen, Murat Rheumatoid arthritis Systemic lupus erythematosus Mortality |
title_short |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality |
title_full |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality |
title_fullStr |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality |
title_full_unstemmed |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality |
title_sort |
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality |
author |
Icen, Murat |
author_facet |
Icen, Murat Nicola, Paulo J. Maradit-Kremers, Hilal Crowson, Cynthia S. Therneau, Terry M. Matteson, Eric L. Gabriel, Sherine E. |
author_role |
author |
author2 |
Nicola, Paulo J. Maradit-Kremers, Hilal Crowson, Cynthia S. Therneau, Terry M. Matteson, Eric L. Gabriel, Sherine E. |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Icen, Murat Nicola, Paulo J. Maradit-Kremers, Hilal Crowson, Cynthia S. Therneau, Terry M. Matteson, Eric L. Gabriel, Sherine E. |
dc.subject.por.fl_str_mv |
Rheumatoid arthritis Systemic lupus erythematosus Mortality |
topic |
Rheumatoid arthritis Systemic lupus erythematosus Mortality |
description |
Copyright © 2009 The Journal of Rheumatology. All rights reserved. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008 2008-01-01T00:00:00Z 2016-04-07T15:45:30Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/23331 |
url |
http://hdl.handle.net/10451/23331 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
J Rheumatol 2009;36:50–57 0315-162X 10.3899/jrheum.080091 |
dc.rights.driver.fl_str_mv |
metadata only access info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
metadata only access |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Earl D. Silverman |
publisher.none.fl_str_mv |
Earl D. Silverman |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134317099614208 |